z-logo
open-access-imgOpen Access
Histone deacetylase inhibitor trichostatin A synergistically resensitizes a gemcitabine resistant urothelial carcinoma cells via suppression of TG-interacting factor and AKT activation
Author(s) -
BiWen Yeh,
WeiMing Li,
ChingChia Li,
Wan-Yi Kang,
ChunNung Huang,
TzyhChyuan Hour,
ZiMiao Liu,
HueiSheng Huang,
WenJeng Wu
Publication year - 2015
Publication title -
urological science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 8
eISSN - 1879-5234
pISSN - 1879-5226
DOI - 10.1016/j.urols.2015.06.204
Subject(s) - trichostatin a , medicine , histone deacetylase inhibitor , cancer research , gemcitabine , histone deacetylase , protein kinase b , urothelial carcinoma , histone , cancer , bladder cancer , signal transduction , microbiology and biotechnology , biology , genetics , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom